Suppression of tumor formation in vivo by expression of the JE gene in malignant cells.
about
Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesisMolecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tailsBTG1, a member of a new family of antiproliferative genesImpact of Tumor-Derived CCL2 on Macrophage Effector FunctionProduction of monocyte chemotactic protein-1 by rat brain macrophagesChemokines: extracellular messengers for all occasions?Regulation of MCP-1 chemokine transcription by p53Enhancement of anti-tumor immunity by tumor cells transfected with the secondary lymphoid tissue chemokine EBI-1-ligand chemokine and stromal cell-derived factor-1alpha chemokine genes.Chemokine signaling in cancer: Implications on the tumor microenvironment and therapeutic targetinggro-beta, a -C-X-C- chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in miceVaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.Monocyte chemoattractant protein-1/CCL2 produced by stromal cells promotes lung metastasis of 4T1 murine breast cancer cells.Chemokines and antitumor immunity: walking the tightrope.Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells.Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines.Protection against lethal bacterial infection in mice by monocyte-chemotactic and -activating factor.Differential expression of the monocyte chemoattractant protein-1 gene in human papillomavirus-16-infected squamous intraepithelial lesions and squamous cell carcinomas of the cervix uteriMonocyte chemoattractant protein-1 gene expression in prostatic hyperplasia and prostate adenocarcinoma.Crosstalk between Tumor Cells and Macrophages in Stroma Renders Tumor Cells as the Primary Source of MCP-1/CCL2 in Lewis Lung Carcinoma.Chemokine gene transfection into tumour cells reduced tumorigenicity in nude mice in association with neutrophilic infiltration.Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gammaThe Yin/Yan of CCL2: a minor role in neutrophil anti-tumor activity in vitro but a major role on the outgrowth of metastatic breast cancer lesions in the lung in vivo.IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo.Overexpressing the CCL2 chemokine in an epithelial ovarian cancer cell line results in latency of in vivo tumourigenicityA dominant negative inhibitor indicates that monocyte chemoattractant protein 1 functions as a dimer.Reduced expression of chemokine (C-C motif) ligand-2 (CCL2) in ovarian adenocarcinomaDifferential regulation of the JE gene encoding the monocyte chemoattractant protein (MCP-1) in cervical carcinoma cells and derived hybrids.The product of a novel growth factor-activated gene, fic, is a biologically active "C-C"-type cytokineA role for CCL2 in both tumor progression and immunosurveillance.New therapy with ASC-J9® to suppress the prostatitis via altering the cytokine CCL2 signals.Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer.Chemokines in cancer development and progression and their potential as targeting molecules for cancer treatment.Membrane-bound form of monocyte chemoattractant protein-1 enhances antitumor effects of suicide gene therapy in a model of hepatocellular carcinoma.Optimal amount of monocyte chemoattractant protein-1 enhances antitumor effects of suicide gene therapy against hepatocellular carcinoma by M1 macrophage activation.Monocyte chemoattractant protein-1 gene delivery enhances antitumor effects of herpes simplex virus thymidine kinase/ganciclovir system in a model of colon cancer.Chemokines, a family of chemotactic cytokines.Genetically engineered tumor vaccines.hTERT-promoter-based tumor-specific expression of MCP-1 effectively sensitizes cervical cancer cells to a low dose of cisplatin.Do chemokines mediate inflammatory cell invasion of the central nervous system parenchyma?Purification and identification of chemokines potentially involved in kidney-specific metastasis by a murine lymphoma variant: induction of migration and NFkappaB activation.
P2860
Q22253275-9E737183-BC0E-470E-BA85-724D1BD2BD04Q24310185-CFFA9ADB-5138-415F-8DF3-6A4D70D10991Q24338576-DECB1910-3903-4CCD-8AC7-54A4903C558CQ24806552-9449D8C7-3F5D-43E2-AD5B-F2FAD03AA0E0Q28572493-4C00A0F5-DFBE-4225-B594-3479DFABE92DQ33539653-3FAC16AB-0FD5-4834-B7E0-4C6ECBCC5AFEQ33828413-FE350557-B60C-4D1A-87B7-F618DB947608Q33939602-5D04E388-1834-4A59-8B4E-28F719568C96Q34010429-A6132FD6-CC4C-4B54-A4D3-12028345F6E6Q34290327-057DE80B-AEEE-4E8A-AF54-3781D1013C8BQ34334817-EAD62F37-C81B-4434-BCAE-562B86C6F035Q34634293-0FB09DD0-B525-4597-BC2C-08672EA0F16BQ35126970-DB16C999-99EF-4EEC-8530-5BEE4BC292E5Q35237477-9F8B93E2-7325-4DA7-B716-9E550D653F5CQ35764436-0711C553-EFFA-4016-86B5-698811228D28Q35772428-8B865D1C-09F6-4BE1-9773-FF6E37873EE9Q35782511-7A992B4C-E931-4718-9F78-6FF667DB4AEFQ35782630-05EDFBBB-4C4E-46CB-97C8-7CFBF5A77E3EQ35782923-00651889-21DA-4E22-9013-810608C16769Q36081142-5AD9B435-4E6E-4E02-9177-A8FEE2BA7644Q36199032-C65B9E7E-4FB7-4F79-8CB1-1D336F1A3465Q36265616-418F27C2-4230-4AEC-8DDC-1AA2EEAFC7C8Q36362293-3ACF7791-D521-4335-9CAE-25B709C707C5Q36415124-9DF7F278-FF55-464B-B6A0-FA7D911F7B42Q36554378-FF8EE971-6D1D-4101-9485-91A62AFE6ED0Q36615915-AEFC775F-9BA7-4B52-8B26-13E4E2722073Q36631278-83429585-C146-48BF-B62B-212B00BC94B2Q36778420-DD0FC801-9846-4193-9303-F51C5D7EE594Q37195262-103EBA11-F7D5-4981-BEF0-26A12EFF2214Q37687068-81D02417-BA33-4877-BC8E-67335A7079DAQ37930487-6F7EFB24-03EE-4E8B-B621-867B5912EC56Q38223355-DA238F77-BCC2-4F3E-A27E-C6332E05CF9BQ39382979-D85B1475-82CC-4569-86CC-431D62F459F7Q39915174-98F785DE-0C20-42A2-A210-76374078977EQ40362152-FDF81D4E-CA1A-4B02-BB06-AF9BE279F2F7Q40406074-D1387CAF-F4D5-4563-9BD6-3A3AD06E90FFQ40489810-6EDF7697-A7B4-4544-B75F-7CE826F4B1CAQ40606275-67945F3B-F8BE-45EB-B758-8B5648144C24Q40689750-635C3901-5815-487F-B96D-08D7298597AAQ41059433-074AA007-E6F1-4706-9BCD-07ED50C33FCB
P2860
Suppression of tumor formation in vivo by expression of the JE gene in malignant cells.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Suppression of tumor formation in vivo by expression of the JE gene in malignant cells.
@en
type
label
Suppression of tumor formation in vivo by expression of the JE gene in malignant cells.
@en
prefLabel
Suppression of tumor formation in vivo by expression of the JE gene in malignant cells.
@en
P2860
P356
P1476
Suppression of tumor formation in vivo by expression of the JE gene in malignant cells.
@en
P2093
B J Rollins
M E Sunday
P2860
P304
P356
10.1128/MCB.11.6.3125
P407
P577
1991-06-01T00:00:00Z